Alpha Teknova, Inc.

TKNO Nasdaq SEC CIK 1850902
Follow Alpha Teknova Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $12.7M +21.5% vs same quarter last year
Net income −$3.5M +18.6% vs same quarter last year
EPS, diluted −$0.06 +25% vs same quarter last year
Operating cash flow −$1.3M +35.5% vs same quarter last year
Revenue by quarter
$9.3M
$9.8M
$10.3M
$10.5M
$10M
$11.1M
$12.2M
$12.7M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−$50M−$25M$0$25M$50MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$40.5M−$17.3M
FY24$37.7M−$26.7M
FY23$36.7M−$36.8M
FY22$41.4M−$47.5M
FY21$36.9M−$9.8M
FY20$31.3M$3.6M
FY19--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−150%−100%−50%0%50%100%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2533.2%−41.9%−42.6%
FY2419.2%−69.3%−70.9%
FY2328.1%−96.9%−100.3%
FY2242.2%−119.9%−114.6%
FY2147.8%−32.5%−26.6%
FY2056.7%14.9%11.4%
FY19---
Free cash flowOperating cash flow minus capital expenditure
−$60M−$40M−$20M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$9.8M
FY24−$13.5M
FY23−$26.7M
FY22−$55.5M
FY21−$28.9M
FY20−$3M
FY19-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Alpha Teknova
  • Healthcare median
−150%−100%−50%0%50%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearAlpha TeknovaHealthcare median
FY25−42.6%−30.6%
FY24−70.9%−47%
FY23−100.3%−58%
FY22−114.6%−80.4%
FY21−26.6%−71.9%
FY2011.4%−62.2%
FY19-−46.3%